Photo by Sam Moqadam on Unsplash
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Gareth Sheridan, CEO of Nutriband NTRB, was a guest speaker on Benzinga’s All Access Events on February 4th, 2022.
He discussed how Nurtriband, by focusing exclusively on transdermal solutions, fills in an important gap in the pharmaceutical market.
Watch the full interview here.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
